ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 118 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.92 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48 | -36.0% | 15,027 | 0.0% | 0.00% | – |
| Q2 2023 | $75 | +2400.0% | 15,027 | +2708.8% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 535 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 535 | +28.6% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 416 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -53.8% | 416 | -14.6% | 0.00% | – |
| Q3 2021 | $13,000 | +85.7% | 487 | +74.6% | 0.00% | – |
| Q2 2021 | $7,000 | -30.0% | 279 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | +42.9% | 279 | +5.7% | 0.00% | – |
| Q4 2020 | $7,000 | -76.7% | 264 | -66.5% | 0.00% | – |
| Q3 2020 | $30,000 | +130.8% | 787 | +14.4% | 0.00% | – |
| Q2 2020 | $13,000 | 0.0% | 688 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | -27.8% | 688 | 0.0% | 0.00% | – |
| Q4 2019 | $18,000 | – | 688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |